Stock Ticker

  • Loading stock data...

Walgreens Boots Alliance Inc (NASDAQ:WBA) Announces Plans To Shut Down 200 Stores In The U.S Due To Cost Cutting

Walgreens Boots Alliance Inc (NASDAQ:WBA) revealed in a regulatory filing on Tuesday that it plans to shut down 200 of its outlets in the U.S as part of its cost-cutting efforts. The company filed a regulatory filing on Tuesday, through which it revealed the plan to close down more than 200 stores in the U.S. […]

Medexus Pharma Revenue and Profits Surge on Acquisitions

Following Monday’s closing bell, Canadian specialty pharma company Medexus Pharmaceuticals (TSX-V:MDP)(OTCQB:PDDPF) released its results from operations for the quarter and fiscal year ended March 31, 2019 showing a dramatic improvement in the top and bottom lines compared to a year earlier.  The books were catalyzed by the company formerly known as Pediapharm completing mergers with […]

Novartis AG (NYSE:NVS) Announces New Clinical Study Updates at the ASCO 2019 Meeting

Novartis AG (NYSE:NVS) posted new clinical study updates in NSCLC at the recently held ASCO 2019 Annual Meeting. This comprised primary efficacy data from the GEOMETRY mono-1 Phase 2 clinical study. It showed that INC280 comes as a potential treatment alternative for subjects with metastatic or locally advanced NSCLC that has MET exon-14 skipping mutation. […]

Merck & Co., Inc. (NYSE:MRK) Gets FDA Nod For ZERBAXA

Merck & Co., Inc. (NYSE:MRK) reported that the U.S. Food and Drug Administration has approved expanded use of its antibiotic to cure hospital-acquired pneumonia in people 18 years and older. This nod comes on the back of the treatment’s late-stage study data, which indicated that Zerbaxa was effective as an antibacterial drug. Zerbaxa was included […]

OncBioMune Shows Compelling Results Compared to Paclitaxel in Ovarian Cancer Experiment

Despite a plethora of advancements in cancer care in recent decades, ovarian cancer remains a great challenge.  In 2019, an estimated 22,530 women will be diagnosed with the ovarian cancer, while the disease will take the lives of about 13,980 women, making it the fifth most lethal form of cancer in the U.S. It was […]

Reverse Split Salvages Nasdaq Listing for Auris Medical

At the end of April, Auris Medical Holding (NASDAQ: EARS) said that it was performing a 1-for-20 reverse split of its stock, effective at the start of this month.   The share consolidation was underpinned by warnings from Nasdaq that the Switzerland-based company was facing delisting because its stock price was below the minimum bid threshold per […]

Re-emergence of Noblis Health Corp. (NYSEAMERICAN:HLTH) Back to Dual Listing

Nobilis Health Corp. (NYSEAMERICAN:HLTH), to list shares on Canadian NEO exchange Nobilis Health Corp is a comprehensive management and healthcare company with a recorded more than 30 units across Arizona and Texas. Nobilis aims to begin listing on the Canadian exchange NEO. The company’s dual listing is aimed at enabling better access by the investors […]

Chembio Diagnostics Inc (NASDAQ:CEMI) Announces Results Of Its Latest Clinical Trial

The stock of Chembio Diagnostics Inc (NASDAQ:CEMI) closed at $7.70 gaining 0.65% in yesterday’s trading session. Chembio Diagnostics has already completed its most recent clinical trial that targeted evaluating its DPP® HIV-Syphilis System. At the moment, it has plans underway to file for a Pre-Market Approval (PMA) submission. That will of course be with the Food and […]

CarpX™ Of PAVmed Inc (NASDAQ:PAVMU) Receives Recognition As An Outstanding Innovation

The stock of PAVmed Inc (NASDAQ:PAVMU) closed at $14.50 gaining 5.45% in yesterday’s trading session. PAVmed takes great pride in the fact that CarpX™ got one of the top four slots awarded by the Technology Innovation category of the 2017 Fierce Innovation Awards. PAVmed’s Chairman and Chief Executive Officer, Lishan Aklog opined, “PAVmed is honored […]

Novavax, Inc. (NASDAQ:NVAX) Shares Fall On RSV, NanoFlu Vaccine Updates

At the star of this year, analysts predicted that investors in Novavax, Inc. (NASDAQ:NVAX) would be keenly watching for any update in December that could give any signal the future of Gaithersburg biotech. On the contraly, investors got a different announcement. The company’s shares went down by 22% on Tuesday. This was triggered by the […]

Sprint Corp (NYSE:S) Takes Top Honours In Chicagoland’s Internet Speed Tests

Speed tests conducted by independent testing and metrics firm, Ookla Speedtest, have revealed that Sprint Corp (NYSE:S) took the crown in 16 Chicagoland cities with regards to the fastest internet download speeds. Sprint recently completed a network upgrade in nine Chicagoland public venues. “…customers now have another reason to switch to Sprint. The Ookla wins […]

CVS Health Corp (NYSE:CVS) and Optum Expansion Triggers Hospital Consolidation

Only a week after CVS Health Corp (NYSE:CVS) announced it had acquired health insurer Aetna, a number of faith based not-for-profit hospital operators are consolidating to form regional health giants to ward off competition. With the expansion of CVS Health and Optum, which intend to acquire dozens of doctor clinics, low cost health providers and […]

Galectin Therapeutics Inc (NASDAQ:GALT) Reports Data From Phase 2b NASH-CX Study

Galectin Therapeutics Inc (NASDAQ:GALT) reported that its Phase 2b NASH-CX study of GR-MD-02 demonstrated statistically notable and clinically meaningful data in lowering the primary endpoint measurement of hepatic venous pressure gradient against placebo in NASH cirrhosis subjects without esophageal varices, which showcased 50% of the patients registered in the clinical study. The details Galectin noted […]

PhaseRx Inc (NASDAQ:PZRX) Updates On Orphan Drug Designation For PRX-ASL

PhaseRx Inc (NASDAQ:PZRX) reported that the European Medicines Agency’s COMP has given a positive view recommending orphan medicinal product status for PRX-ASL, for the cure of argininosuccinate lyase deficiency, the company’s second drug candidate to cure a urea cycle disorder. The details ASLD can be stated as a rare liver disorder, which is a result […]

How Egalet Corp (NASDAQ:EGLT) Fared In Q3 2017?

Egalet Corp (NASDAQ:EGLT) issued financial report for the third quarter closed September 30, 2017. As of September 30, 2017, the company recorded cash/cash equivalents and marketable securities of $102.1 million. Total net product sales came at $6.7 million for the quarter closed September 30, 2017 versus $4.7 million for the quarter closed September 30, 2016. […]

Sign Up To Get Our Latest Stocks Alerts